Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003023000A2 Linear dna fragments for gene expression
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022991A2 Compositions and methods of use of targeting peptides against placenta and adipose tissues
03/20/2003WO2003022990A2 Production of fusion proteins and use for identifying binding molecules
03/20/2003WO2003022988A2 Adipose-derived stem cells and lattices
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022884A2 Methods for construction and screening of libraries of chemokine variants
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022874A1 Antagonist peptides to vegr receptor flt-1
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022868A2 Metal binding proteins and associated methods
03/20/2003WO2003022867A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
03/20/2003WO2003022862A1 Cct protein expression promoter
03/20/2003WO2003022858A2 Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
03/20/2003WO2003022439A2 Zone heating of specimen carriers
03/20/2003WO2003022421A2 Microcolumn-platform based array for high-throughput analysis
03/20/2003WO2003022311A1 Adenoviral vector and related system and methods of making and use
03/20/2003WO2003022307A1 Attenuated bacteria useful in vaccines
03/20/2003WO2003022306A2 Bacterial vaccine
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022228A2 Method for producing transgenic birds and fish
03/20/2003WO2003022227A2 Antisense modulation of vascular endothelial growth factor receptor-1 expression
03/20/2003WO2003022225A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003WO2003022222A2 Antisense modulation of protein kinase r expression
03/20/2003WO2003022220A2 Method of generating a transgenic livestock animal
03/20/2003WO2003022212A2 Anti-tumor effects of prostate carcinoma tumor antigen-1
03/20/2003WO2003022205A2 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
03/20/2003WO2003022204A2 Measles vaccine vectors and methods of use
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003022056A1 Use of acetohydroxy acid isomeroreductase inhibitors for treating fungal diseases affecting crops
03/20/2003WO2003022052A1 Method for expression of small rna molecules within a cell
03/20/2003WO2003022043A1 Hair follicle-reconstitution system and animal carrying the same
03/20/2003WO2003022042A1 Enhanced resolution of tumor metastasis
03/20/2003WO2003022040A2 Method for producing transgenic animals
03/20/2003WO2003022039A1 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein
03/20/2003WO2003022032A2 Method for increasing stress tolerance in plants
03/20/2003WO2003022028A2 Methods, reagents, kits and apparatus for protein function analysis
03/20/2003WO2003002726A3 Cellular reporter gene assay with a ligand amplifying feedback loop
03/20/2003WO2003002597A3 Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein
03/20/2003WO2003000724A3 Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders
03/20/2003WO2003000280A3 Abin-mediated hepatitis protection
03/20/2003WO2002101092A3 Oligonucleotides for detecting hybridisation
03/20/2003WO2002099094A3 Human serine/threonine protein kinase-like enzyme
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002099067A3 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
03/20/2003WO2002098361A3 T cell induced tissue repair and regeneration
03/20/2003WO2002097135A9 Accurate and efficient quantification of dna sensitivity by real-time pcr
03/20/2003WO2002097100A3 Cloning vectors for homologous recombination and method using same
03/20/2003WO2002097065A3 Remodeling of somatic nuclei upon addition of pluripotent cell extracts
03/20/2003WO2002095021A8 A repressor-mediated regulation system for control of gene expression in plants
03/20/2003WO2002094983A3 Dna-antibody complexes to enhance gene transfer
03/20/2003WO2002092786A3 A helper dependent adenoviral vector system and methods for using the same
03/20/2003WO2002092775A3 Tumor antigen homologous to poly(a) polymerase
03/20/2003WO2002090545A9 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
03/20/2003WO2002088353A3 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof
03/20/2003WO2002088340A3 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002085285A3 Methods and reagents for regulating bone and cartilage formation
03/20/2003WO2002083927A3 Universal multi-variant detection system
03/20/2003WO2002081686A3 Nucleic acids binding a neuropeptide
03/20/2003WO2002081500A3 Methods for enhancing a plant stress response
03/20/2003WO2002079490A9 Bio-barcodes based on oligonucleotide-modified particles
03/20/2003WO2002079487A3 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism
03/20/2003WO2002079449A3 Molecules for disease detection and treatment
03/20/2003WO2002079413A3 TRANSGENIC MICE HAVING A DISRUPTION IN β-1,3,N-ACETYLGLUCOSAMINYLTRANSFERASE
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002078614A3 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
03/20/2003WO2002078438A3 Tissue-preferred promoter from maize
03/20/2003WO2002077184A3 Oligonucleotide conjugates
03/20/2003WO2002074966A3 Process for the preparation of l-amino acids by using coryneform bacteria
03/20/2003WO2002074045A3 Production of pancreatic islet cells and delivery of insulin
03/20/2003WO2002072846A9 Synthetic genes and bacterial plasmids devoid of cpg
03/20/2003WO2002072024A3 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
03/20/2003WO2002070554A3 Dna encoding human cid2
03/20/2003WO2002069908A3 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
03/20/2003WO2002068603A9 Materials and methods for the induction of premature chromosome condensation
03/20/2003WO2002068458A3 Disintegrin homolog, zsnk16
03/20/2003WO2002062989A3 Methods of light activated release 0f ligands from endosomes
03/20/2003WO2002060934A3 IDENTIFICATION OF THE ANTI-σ28 FACTOR IN HELICOBACTER PYLORI, IN CAMPYLOBACTER JEJUNI AND IN PSEUDOMONAS AERUGINOSA AND APPLICATION THEREOF
03/20/2003WO2002059325A3 Human kinases and polynucleotides encoding the same
03/20/2003WO2002057447A3 Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences
03/20/2003WO2002053760A3 Chimeric cytolytic viruses for cancer treatment
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002053582A3 Process for producing peptides by using in vitrotranscription/translation system
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046417A3 Adipocyte complement related protein zacrp3x2
03/20/2003WO2002046359A8 INDUCIBLE HIGHLY PRODUCTIVE rAAV PACKAGING CELL-LINES
03/20/2003WO2002045490A3 Method of cloning animals
03/20/2003WO2002045472A3 SEQUENCE SPECIFIC AND SEQUENCE NON-SPECIFIC METHODS AND MATERIALS FOR cDNA NORMALIZATION AND SUBTRACTION
03/20/2003WO2002042447A3 Surface transfection and expression procedure
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002033103A3 Non-human mammal with modified pacap type i receptor
03/20/2003WO2002029051A3 Human secretin receptor-like gpcr
03/20/2003WO2002028408A3 Compositions and methods for the transport of biologically active agents across cellular barriers
1 ... 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 ... 4023